AIM
PFE icon

Anchor Investment Management’s Pfizer PFE Stock Holding History

Anchor Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$26.5K – 1050
2024
Q4 		$26.5K Hold
1,000
– – ﹤0.01% 667
2024
Q3 		$28.9K Hold
1,000
– – ﹤0.01% 647
2024
Q2 		$28K Buy
+1,000
New +$27.5K ﹤0.01% 595

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Anchor Investment Management's PFE Position: Q2 2026 in Review

Anchor Investment Management reduced its Pfizer (PFE) stake by 3.3% in Q2 2026, selling an estimated $75.8K and leaving 84,672 shares worth $2.04M. The position accounts for 0.15% of the portfolio, ranked #140.

Anchor Investment Management first reported a position in PFE in Q1 2016 and has held it in 42 quarters since. The position peaked at $9.36M in Q4 2021. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Anchor Investment Management held 84,672 shares of Pfizer worth $2.04M as of Q2 2026.
  • Anchor Investment Management sold 2,896 Pfizer shares in Q2 2026, an estimated $75.8K.
  • Pfizer made up 0.15% of Anchor Investment Management's portfolio in Q2 2026, its #140 holding.
  • Anchor Investment Management first reported a position in Pfizer in Q1 2016 and has held it in 42 quarters since.
  • Anchor Investment Management's Pfizer position peaked at $9.36M in Q4 2021.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Anchor Investment Management's 13F filing for Q2 2026, filed 15 Sep 2026.